Skip to main content

Find Clinical Trials

Home
Conditions
Healthy

Clinical trial condition

Healthy

Explore clinical trials studying Healthy. Study availability and eligibility vary by location and protocol.

9,866 public trials 449 recruiting studies

Refine in advanced search Browse all conditions

Healthy trial results

Completed

Safety, Tolerability and Pharmacokinetics of the Fixed Dose Combination of BI 1744 CL Plus BI 54903 XX Via Respimat® B Versus the Mono Products of BI 1744 CL Via Respimat® A and BI 54903 XX Via Respimat® B in Healthy Male and Female Volunteers

NCT02222428

Conditions: Healthy
Locations: Not specified

View Trial Details

Completed

Bioequivalence of a 2.5 mg Linagliptin / 850 mg Metformin Fixed Dose Combination Tablet Compared With Single Linagliptin 2.5 mg and Metformin 850 mg Tablets in Healthy Volunteers

NCT02220647

Conditions: Healthy
Locations: Not specified

View Trial Details

Completed

Relative Bioavailability of Different Formulations of BI 671800 in Healthy Male and Female Volunteers

NCT02221388

Conditions: Healthy
Locations: Not specified

View Trial Details

Completed

Bioequivalence of a 2.5 mg Linagliptin / 500 mg Metformin Fixed Dose Combination Tablet Compared With Single Linagliptin 2.5 mg and Metformin 500 mg Tablets Administered Together in Healthy Volunteers

NCT02221414

Conditions: Healthy
Locations: Not specified

View Trial Details

Completed

Safety, Tolerability and Pharmacokinetics of the Fixed Dose Combination of BI 1744 CL Plus BI 54903 XX Via Respimat® B Versus the Free Combination of BI 1744 CL Via Respimat® A and BI 54903 XX Via Respimat® B in Healthy Male and Female Volunteers

NCT02220660

Conditions: Healthy
Locations: Not specified

View Trial Details

Completed

The Impact of Proton Pump Inhibitors on the Fecal Microbiome

NCT01822977

Conditions: Bacterial Infections, Bacterial Infections and Mycoses, Clostridium Difficile Infection, +4 more
Locations: Mayo Clinic in Arizona Scottsdale, Arizona, United States

View Trial Details

Completed

Safety, Tolerability and Pharmacokinetics of Multiple Rising Doses of Butylated Hydroxytoluene and BI 54903 XX Via Respimat® Soft MistTM Inhaler B in Healthy Male Volunteers

NCT02221375

Conditions: Healthy
Locations: Not specified

View Trial Details

Completed

Bioequivalence of a Linagliptin / Metformin Fixed-dose Combination (FDC) Tablet Compared With Single Linagliptin and Metformin Tablets Administered Together in Healthy Volunteers

NCT02221401

Conditions: Healthy
Locations: Not specified

View Trial Details

Completed

Single Dose Pharmacodynamic and Pharmacokinetic Study of DG3173

NCT02217826

Conditions: Healthy
Locations: Not specified

View Trial Details

Completed

Relative Bioavailability of 2 Fixed Dose Combinations of Linagliptin/Metformin Compared With Single Tablets

NCT01845077

Conditions: Healthy
Locations: 1288.8.1 Boehringer Ingelheim Investigational Site Austin, Texas, United States

View Trial Details